Previous 10 | Next 10 |
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) today announced that it has received the permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations as per t...
Dr. Reddy’s Laboratories (RDY) announces the launch of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg, a therapeutic equivalent generic version of Kuvan Powder for Oral Solution, 100 mg. For further details see: Dr. Reddy's launches generic Sapropterin Dihydrochlori...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg, a therapeutic ...
The Indian drug regulator has asked Dr. Reddy's Laboratories ([[RDY]] +1.3%) to provide more data regarding its application seeking the emergency use approval for Sputnik V, the coronavirus vaccine developed by Russia.Following the submission for approval filed by the comp...
Dr. Reddy’s Laboratories (RDY) announces the launch of Lansoprazole DR Orally Disintegrating Tablets, a therapeutic equivalent generic version of Takeda Pharma's Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets, 15 mg and 30 mg. The Prevacid brand and generic had U.S. sal...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Lansoprazole DR Orally Disintegrating Tablets, a therapeutic equivalent gen...
Dr. Reddy’s Laboratories (RDY) has initiated the process with the Drugs Controller General of India for Emergency Use Authorization ((EUA)) of human adenoviral vector-based platform vaccine candidate, Sputnik V. As part of the review process, Dr. Reddy’s will present the sa...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has initiated the process with the Drugs Controller General of India (DCGI) for Em...
Dr. Reddy’s Laboratories (RDY) announces the launch of Fluphenazine Hydrochloride Tablets, USP, a therapeutic equivalent generic version of Prolixin Tablets, 1 mg, 2.5, 5, and 10 mg. According to IQVIA Health, Prolixin brand and generic had U.S. sales of ~$134M for twelve months ended ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fluphenazine Hydrochloride Tablets, USP, a therapeutic equivalent generic ve...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...